Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
Accessioned
2014-06-12T19:59:52ZAvailable
2014-06-12T19:59:52ZIssued
2014-03-08Metadata
Show full item record